• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
GAO Junfang,SONG Xinyu,ZHU Meiyu,WANG Jing.Applied research of the individual intervention care to prevention of anaphylaxis of Vitamin K1 Injection[J].Journal Of Pharmaceutical Research,2016,35(7):420-421,434[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3436times   Download 2978次 QR Code for this article
Scan with your phone!
个体化干预措施在预防维生素K1注射液过敏反应中的应用研究
高俊芳1,宋新宇2,朱美玉1,王静1
Font:Larger+|Default|Smaller-
(1.滨州医学院附属医院,山东 滨州 256603;2.滨州医学院,山东 滨州 256603)
摘要:
目的 通过对应用维生素K1注射液的患儿实施个体化干预措施,来预防药物不良反应的发生。方法 应用维生素K1注射液患儿均采用稀释后静脉滴注方法给药,两组患儿在接受此药物前均进行药物过敏反应登记。将2014年1月1日~2014年12月31日使用维生素K1注射液治疗的患儿107例作为研究对象,随机分为对照组52例和干预组55例。对照组仅给予常规输液治疗及严密观察,干预组对初次使用和不清楚用药史的患儿给予药物过敏实验,皮试结果为阴性方可输液治疗。结果 对照组有3例发生过敏反应,干预组无过敏反应发生,两组结果的差异有统计学意义(P<0.05)。结论 对应用维生素K1注射液治疗的患儿实施个体化干预措施可有效预防药物过敏反应,保障用药安全,促进医患和谐,减少医患纠纷的发生。
关键词:  患儿  维生素K1注射液  过敏反应  皮肤试验
DOI:10.13506/j.cnki.jpr.2016.07.015
基金项目:山东省滨州市科技发展项目(No.2014zc0113)
Applied research of the individual intervention care to prevention of anaphylaxis of Vitamin K1 Injection
GAO Junfang1,SONG Xinyu2,ZHU Meiyu1,WANG Jing1
(1.Department of Pediatrics of Gastroenterology and Nephrology, Affiliated Hospital of Binzhou Medical University, Binzhou 256603,China;2.Department of Respiratory Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou 256603,China)
Abstract:
Objective To prevent the side effects of the Vitamin K1 Injection with the individual intervention care to the infant patients administered the injection.Methods Every infant patient was administered the dilute injection through the intravenous drip and the drug allergy history was registered.107 infant patients administered Vitamin K1. Injection during January 1, 2014 to December 31,2014 were chose as the research participants,who were randomly divided into control group (52 cases) and interventional group (55 cases).The patients in control group received the routine treatment of transfusion and careful observation,while the infants who had the first treatment and unclear history in the interventional group cannot get Vitamin K1 Injection except those who would have the negative results of allergy skin test.Results 3 anaphylactic reactions occurred in control group,whereas no allergy was observed in interventional group(P<0.05).Conclusion The individual intervention care to the infant patients administered Vitamin K1 Injection can provide the efficient prevention of anaphylactic reactions and ensure the drug use.Furthermore,the harmonious doctor-patient relationship would come true and there would be much less medical disputes.
Key words:  Infant patients  Vitamin K1 Injection  Anaphylactic reaction  Skin test
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.